Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma

Blood

Volumn 117, Issue 6, 2011, Pages 2005-2008

  Chevillard, Grégory ^a   Paquet, Marilene ^b   Blank, Volker ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CIGARETTE SMOKE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; LUNG METASTASIS; LYMPHOBLASTOMA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RISK FACTOR;

EID: 79951496021     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-02-271460     Document Type: Article

References (28)

1. Gelboin HV. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev. 1980;60(4):1107-1166.
2. de Vries A, van Oostrom CT, Dortant PM, et al. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol Carcinog. 1997;19(1):46-53. (Pubitemid 27237224)
3. Zienolddiny S, Ryberg D, Svendsrud DH, et al. Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis. Int J Cancer. 2006;118(11):2899-2902. (Pubitemid 43673374)
4. Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41(2):89-295.
5. Ramos-Gomez M, Dolan PM, Itoh K, Yamamoto M, KenslerTW. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice. Carcinogenesis. 2003;24(3):461-467. (Pubitemid 36432641)
6. Ramos-Gomez M, Kwak MK, Dolan PM, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice [see comment]. Proc Natl Acad Sci U S A. 2001;98(6): 3410-3415. (Pubitemid 32220859)
7. Nouhi Z, Chevillard G, Derjuga A, Blank V. Endoplasmic reticulum association and N-linked glycosylation of the human Nrf3 transcription factor. FEBS Lett. 2007;581(28):5401-5406. (Pubitemid 350101521)
8. Zhang Y, Kobayashi A, Yamamoto M, Hayes JD. The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence. J Biol Chem. 2009;284(5):3195-3210.
9. Chevillard G, Nouhi Z, Anna D, Paquet M, Blank V. Nrf3-deficient mice are not protected against acute lung and adipose tissue damages induced by butylated hydroxytoluene. FEBS Lett. 2010; 584(5):923-928.
10. Pepe AE, Xiao Q, Zampetaki A, et al. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res. 2010;106(5):870-879.
11. Derjuga A, Gourley TS, Holm TM, et al. Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus. Mol Cell Biol. 2004;24(8):3286-3294. (Pubitemid 38452073)
12. Almstrup K, Leffers H, Lothe RA, et al. Improved gene expression signature of testicular carcinoma in situ. Int J Androl. 2007;30(4):292-302; discussion 303.
13. Obrador-Hevia A, Fernandez de Mattos S, Villalonga P, Rodriguez J. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies. Blood Rev. 2009;23(5): 205-216.
14. Rizzatti EG, Falcao RP, Panepucci RA, et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol. 2005;130(4): 516-526. (Pubitemid 43899754)
15. Ortega-Paino E, Fransson J, Ek S, Borrebaeck CA. Functionally associated targets in mantle cell lymphoma as defined by DNAmicroarrays and RNA interference. Blood. 2008;111(3):1617-1624. (Pubitemid 351213453)
16. Willenbrock K, Kuppers R, Renne C, et al. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica. 2006;91(5): 596-604. (Pubitemid 43799453)
17. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111(4):529-537. (Pubitemid 36228010)
18. Rhee DK, Park SH, Jang YK. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. Genomics. 2008;92(6):419-428.
19. Almstrup K, Ottesen AM, Sonne SB, et al. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ. Cell Tissue Res. 2005;322(1):159-165. (Pubitemid 41677668)
20. Thieblemont C, Nasser V, Felman P, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood. 2004;103(7):2727-2737. (Pubitemid 38393031)
21. Holcomb VB, Vogel H, Marple T, Kornegay RW, Hasty P. Ku80 and p53 suppress medulloblastoma that arise independent of Rag-1-induced DSBs. Oncogene. 2006;25(54):7159-7165. (Pubitemid 44764185)
22. Hodges E, Krishna MT, Pickard C, Smith JL. Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol. 2003;56(1):1-11. (Pubitemid 36132467)
23. Morse HC 3rd, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 2002;100(1):246-258. (Pubitemid 35177454)
24. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89(11):3909-3918.
25. Chiaretti S, Foa R. T-cell acute lymphoblastic leukemia. Haematologica. 2009;94(2):160-162.
26. Cauwelier B, Cave H, Gervais C, et al. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia. 2007;21(1):121-128. (Pubitemid 44921843)
27. Karrman K, Forestier E, Heyman M, et al. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome. Genes Chromosomes Cancer. 2009; 48(9):795-805.
28. Speleman F, Cauwelier B, Dastugue N, et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia. 2005;19(3):358-366. (Pubitemid 40403311)